Farhad Adhami Moghadam
Overview
Explore the profile of Farhad Adhami Moghadam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasti S, Mirfeizi M, Afshari M, Hasanzad M, Moghadam F, Aghaei Meybodi H
J Diabetes Metab Disord
. 2024 Jun;
23(1):1183-1187.
PMID: 38932910
Background: Type 2 diabetes mellitus (T2DM) is a complex metabolic disease that occurs as a result of insulin resistance and low insulin production. T2DM involves many organ systems that include...
2.
Salehizadeh S, Ramezani S, Asadi M, Afshari M, Jamaldini S, Moghadam F, et al.
J Diabetes Metab Disord
. 2024 Jun;
23(1):633-638.
PMID: 38932830
Background: Type 2 diabetes mellitus (T2DM) is recognized as a complex metabolic which has affected the lives of millions of people around the world. Vitamin D receptor (VDR) gene polymorphisms...
3.
Hadipour Jahromy M, Qomi M, Fazelipour S, Sami N, Faali F, Karimi M, et al.
Heliyon
. 2024 Apr;
10(7):e29009.
PMID: 38601632
Background: One of the most efficient treatments for dry eye syndrome (DES) is to use nanocarriers as a potential delivery system. We aim to evaluate curcumin in a nano emulsion...
4.
Mirzaei S, Paskeh M, Moghadam F, Entezari M, Koohpar Z, Hejazi E, et al.
J Cell Commun Signal
. 2023 Nov;
17(4):1181-1202.
PMID: 38019354
The treatment of cancer patients has been prohibited by chemoresistance. Doxorubicin (DOX) is an anti-tumor compound disrupting proliferation and triggering cell cycle arrest via inhibiting activity of topoisomerase I and...
5.
Mihandoust S, Nematollahzadeh Z, Shirvani M, Al-Karboolee N, Joudi M, Fouroozandeh M, et al.
J Family Med Prim Care
. 2023 Jan;
11(10):6350-6355.
PMID: 36618150
Introduction: This research aimed to determine the relationship between personality dimensions with the rate of resiliency and internal cohesion regarding the intermediary role of spiritual health in candidate patients for...
6.
Mazlominezhad A, Moghadam F
J Med Life
. 2022 Jun;
15(4):499-503.
PMID: 35646181
Amblyopia is an acquired defect due to a lack of visual stimulation. Self-efficacy is one of the factors affecting the quality of life (QoL) of individuals. Low self-efficacy can decrease...
7.
Daryabari S, Asadollah A, Moghadam F, Dorostkar R, Bahramifar A, Aghamollaei H
Int Ophthalmol
. 2022 Feb;
42(3):729.
PMID: 35147833
No abstract available.
8.
Daryabari S, Asadollah A, Moghadam F, Dorostkar R, Bahramifar A, Aghamollaei H
Int Ophthalmol
. 2021 Nov;
42(3):723-727.
PMID: 34762278
Purpose: Upon the outbreak of 2019, novel coronavirus (COVID-19) pandemic confirmed the cases surpassed 20 million. Despite a few reports identified the association of severe acute respiratory syndrome coronavirus 2...
9.
Moghadam F, Azad S, Sahebalzamani M, Farahani H, Jamaran M
J Family Med Prim Care
. 2018 Mar;
6(4):784-790.
PMID: 29564264
Introduction: Having awareness, interest, and positive attitude toward one's fields of study leads to the development of a compatibility between demands and expectations on the one hand and future career...